Pharmaron Beijing Co., Ltd. (HKG:3759)
Hong Kong
· Delayed Price · Currency is HKD 15.38
-1.46 (-8.67%)
Feb 28, 2025, 4:08 PM HKT
Pharmaron Beijing Market Cap
Pharmaron Beijing has a market cap or net worth of 49.27 billion as of February 28, 2025. Its market cap has increased by 12.06% in one year.
Market Cap
49.27B
Enterprise Value
53.42B
Revenue
13.06B
Ranking
n/a
PE Ratio
23.61
Stock Price
15.38
Market Cap Chart
Since January 28, 2019, Pharmaron Beijing's market cap has increased from 8.42B to 49.27B, an increase of 485.06%. That is a compound annual growth rate of 33.67%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeiGene | 214.44B |
| Hansoh Pharmaceutical Group Company | 112.51B |
| JD Health International | 110.51B |
| WuXi Biologics | 95.66B |
| Alibaba Health Information Technology | 88.13B |
| Innovent Biologics | 66.10B |
| Akeso | 64.09B |
| Sinopharm Group | 61.98B |